Chelsea Shkreli

Extracted Attributes

Martin Shkreli

Martin Shkreli (; born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016. In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price to insurance companies from $13.50 to $750.00 (USD) per pill, sparking a scandal in the United States and around the world, cementing his reputation as 'the most hated man in America'. In 2017, Shkreli was convicted in federal court on two counts of securities fraud and one count of conspiracy. He was sentenced to seven years in prison and up to $7.4 million in fines. In the civil antitrust case, Shkreli was fined a further $64.6 million to be repaid to victims. In May 2022, he was released early from the low-security federal prison in Allenwood, Pennsylvania. He is permanently banned from serving as an officer of any publicly traded company.

Web Search Results

• Chelsea Shkreli — 2 mentions on Teahose

  HOME/PEOPLE/CHELSEA SHKRELI // PERSON # Chelsea Shkreli ROLE EARLY OPENAI EMPLOYEEAT OPENAIMENTIONS 2LAST SEEN OCTOBER 12, 2026 // BIO Chelsea Sierra Voss is a computer scientist and member of the technical staff at OpenAI, where she has worked since September 2019. She graduated from MIT with bachelor's and master's degrees in computer science and previously taught quantum computing with Scott Aaronson. She is known for her work in theoretical computer science, computational biology, and software engineering at companies including Pilot and Sendwave prior to joining OpenAI. // RECENT MENTIONS // SIGNALS 2SIGNALS 01 mention·All In·OCTOBER 12, 2026 Source→ 02 mention·All In·OCTOBER 12, 2026 Source→ [...] Teahose. SIGN IN NEW HERE — WHAT TEAHOSE DOES We read the entire AI & tech firehose — so you don't have to. HOW IT WORKS → PODPodcasts NEWNewsletters PAPPapers PHProduct Hunt VCInvestor Scout 7 reads, 30 sec each — free, 6 AM ET. + a live graph of the companies, people & themes underneath. NEW HERE — WHAT TEAHOSE DOES We read the entire AI & tech firehose — so you don't have to. PODPodcastsAll-In, No Priors, Acquired… NEWNewslettersStratechery, Newcomer… PAPPapersPhysical AI research PHProduct Huntdaily launches VCInvestor ScoutSequoia, a16z, Benchmark… CLAUDE DISTILLS → 7 reads, 30 sec each — free, 6 AM ET. + a live graph of the companies, people & themes underneath. HOME/PEOPLE/CHELSEA SHKRELI // PERSON # Chelsea Shkreli [...] Source→ 02 mention·All In·OCTOBER 12, 2026 Source→ AI-extracted from podcast / newsletter / paper summaries. May contain errors. Chelsea Shkreli — 2 mentions on Teahose

• 'Pharma Bro' Martin Shkreli broke lifetime ban on drug industry trades, fed say

  The filing also identifies Shkreli’s significant other, Chelsea Voss, and his sister, Leonora Izerne, as people who appear to have helped facilitate his trading. ### Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more. ### Thanks for signing up! In one livestream, Shkreli allegedly asked Voss for $30,000 to cover a potential margin call. Regulators want both women ordered to preserve evidence related to his transactions. The FTC and prosecutors including New York AG Letitia James are demanding that Shkreli provide a sworn accounting of all his pharmaceutical stock trades since February 2022 and submit to a financial audit at his own expense. [...] They also want a court-imposed penalty equal to his profits from those trades, plus interest, without allowing him to deduct losses from losing bets. Regulators are urging US District Judge Denise Cote to establish escalating penalties, including additional fines and possible incarceration, if Shkreli fails to comply with the court’s orders or continues violating the ban. The ban was upheld by a federal appeals court in January 2024, and the Supreme Court declined to review his case later that year. Shkreli, who was separately sentenced to seven years in prison for securities fraud, was released in 2022. The Post has sought comment from Shkreli and his attorney. [...] The feds claim Shkreli, who named his newborn son Torque “EZMONEY$TAXX” Shkreli last year, began his “brazen violations” shortly after leaving prison in 2022 following his securities fraud conviction — livestreaming stock trades on his YouTube channel despite being barred from participating in the drug industry. Shkreli became notorious in 2015 when his company, Turing Pharmaceuticals, remorselessly jacked up the price of the lifesaving antiparasitic drug Daraprim from $17.50 to $750 a pill. He was later ordered to return $64.6 million he made on the drug, a sum that remains unpaid, according to authorities.

• FTC claims Shkreli is in contempt after defying lifetime pharma ban | Courthouse News Service

  The FTC and the states point to Shkreli’s activity on social media platforms — including frequent livestreams and posts on YouTube, X and Reddit — as “likely the tip of the iceberg” of his trading. They note Shkreli himself has publicly intimated he does most of his trading off social media. “I have some other accounts that I’[d] show you, but, like, I know feds are watching, so f[\]ck that,” Shkreli is quoted as saying in the court filing. The regulators are also seeking a court order directing Shkreli — along with his sister, Leonora Izerne, and significant other, Chelsea Voss — to refrain from destroying any potential evidence related to his past, present or future permanent injunction violations, including public online posts. [...] In a pair of court filings Tuesday, the FTC and its state co-plaintiffs claim Shkreli, the biotech entrepreneur infamous for jacking up the price of a lifesaving drug used to treat HIV, has been violating a 2022 injunction by publicly trading pharmaceutical industry stocks and broadcasting his opinions about such companies since his release from prison in May 2022. Shkreli, 43, was convicted for securities fraud charges unrelated to the HIV drug Daraprim in August 2017. In January 2022, he was found liable in a civil case in Manhattan federal court for violating federal and state antitrust laws by acquiring Daraprim, raising the price per pill from $17.50 to $750, and constricting competition from generic drug manufacturers that severely limited supply and put patients at risk. [...] In her ruling, Senior U.S. District Judge Denise Cote banned Shkreli for life from participating in the pharmaceutical industry in any way. On Tuesday, the FTC and the coalition of states attorneys general urged Cote, a Bill Clinton appointee, to hold Shkreli in contempt of the court for openly trading pharmaceutical stocks, publicly discussing the industry and encouraging his social media followers to invest based on his recommendations. They say Shkreli has publicly gloated about taking profitable short positions — bets that a stock will lose value — on numerous small pharmaceutical companies, which are especially vulnerable to short selling. Their stock price can swing dramatically upon certain events, such as FDA approval or the success or failure of a clinical drug study.

• Martin Shkreli - Wikipedia

  Martin Shkreli (/ˈʃkrɛli/; born March 17, 1983) is an American investor and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016. In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price to insurance companies from $13.50 to $750.00 (USD) per pill, sparking a scandal in the United States and around the world, cementing his reputation as 'the most hated man in America'. [...] Shkreli was born in Coney Island Hospital in the New York City borough of Brooklyn on March 17, 1983. His parents were Roman Catholic, and he said his religion has been "a guiding post" for him, although he does not believe in God. His parents emigrated to the United States from Albania and worked as janitors. His two sisters and his brother grew up in a working-class community in Sheepshead Bay, Brooklyn. Shkreli was raised Catholic and attended Sunday school as a child. Shkreli attended Hunter College High School. Sources differ on whether Shkreli graduated from Hunter or whether he was expelled before his senior year and received the credits necessary for his high school diploma through City-As-School High School. He ended up in a program that placed him in an internship at Wall Street [...] 1983 births 2015 controversies in the United States 21st-century American businesspeople 21st-century American criminals American art collectors American businesspeople convicted of crimes American chief executives of financial services companies American chief executives in the manufacturing industry American businesspeople in the entertainment industry American financial analysts American financial company founders American chief executives in the health care industry American hedge fund managers American investors American male criminals American money managers American people convicted of fraud American people of Albanian descent American prisoners and detainees American chief executives in technology American technology company founders Baruch College alumni

• Chelsea Sierra Voss (@csvoss) / X

  Log inSign up Log inSign up Chelsea Sierra Voss Chelsea Sierra Voss profile banner @csvoss # Chelsea Sierra Voss @csvoss engineeress ✨ fmr member of technical staff @openai // ilu @martinshkreli // prev @pilothq, @sendwaveapp, @khanacademy, @MIT, IOL, 2x IBO Joined August 2013 1,870 Following14.6K Followers RepliesRepliesRepostsRepostsMediaMedia @csvoss Chelsea Sierra Voss@csvoss 21h ugh it might finally be time to sicc Astra on making an up-to-date, complete, and BEAUTIFUL version of this poster so that I can finally OWN ONE @zeta_globin zeta@zeta\_globin Oct 11